These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1830860)

  • 1. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide.
    Elliott RB; Chase HP
    Diabetologia; 1991 May; 34(5):362-5. PubMed ID: 1830860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
    Lampeter EF; Klinghammer A; Scherbaum WA; Heinze E; Haastert B; Giani G; Kolb H
    Diabetes; 1998 Jun; 47(6):980-4. PubMed ID: 9604880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).
    European Nicotinamide Diabetes Intervention Trial Group
    Diabetologia; 2003 Mar; 46(3):339-46. PubMed ID: 12687331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
    Cabrera-Rode E; Molina G; Arranz C; Vera M; González P; Suárez R; Prieto M; Padrón S; León R; Tillan J; García I; Tiberti C; Rodríguez OM; Gutiérrez A; Fernández T; Govea A; Hernández J; Chiong D; Domínguez E; Di Mario U; Díaz-Díaz O; Díaz-Horta O
    Autoimmunity; 2006 Jun; 39(4):333-40. PubMed ID: 16891222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.
    Greenbaum CJ; Kahn SE; Palmer JP
    Diabetes; 1996 Nov; 45(11):1631-4. PubMed ID: 8866571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
    Vardi P; Crisa L; Jackson RA
    Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population based strategy to prevent insulin-dependent diabetes using nicotinamide.
    Elliott RB; Pilcher CC; Fergusson DM; Stewart AW
    J Pediatr Endocrinol Metab; 1996; 9(5):501-9. PubMed ID: 8961125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide treatment in subjects at high risk of developing IDDM improves insulin secretion.
    Manna R; Migliore A; Martin LS; Ferrara E; Ponte E; Marietti G; Scuderi F; Cristiano G; Ghirlanda G; Gambassi G
    Br J Clin Pract; 1992; 46(3):177-9. PubMed ID: 1286017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intervention with nicotinamide in pre-type 1 diabetes: the Deutsche Nikotinamid Interventionsstudie-DENIS.
    Lampeter EF
    Diabete Metab; 1993; 19(1 Pt 2):105-9. PubMed ID: 8314411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide.
    Herskowitz RD; Jackson RA; Soeldner JS; Eisenbarth GS
    J Autoimmun; 1989 Oct; 2(5):733-7. PubMed ID: 2529865
    [No Abstract]   [Full Text] [Related]  

  • 11. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.
    Srikanta S; Ganda OP; Rabizadeh A; Soeldner JS; Eisenbarth GS
    N Engl J Med; 1985 Aug; 313(8):461-4. PubMed ID: 3894969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
    Gale EA; Bingley PJ; Emmett CL; Collier T;
    Lancet; 2004 Mar; 363(9413):925-31. PubMed ID: 15043959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
    Lorini R; Alibrandi A; Vitali L; Klersy C; Martinetti M; Betterle C; d'Annunzio G; Bonifacio E;
    Diabetes Care; 2001 Jul; 24(7):1210-6. PubMed ID: 11423504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children.
    Landin-Olsson M; Palmer JP; Lernmark A; Blom L; Sundkvist G; Nyström L; Dahlquist G
    Diabetologia; 1992 Nov; 35(11):1068-73. PubMed ID: 1473617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children.
    Carel JC; Boitard C; Eisenbarth G; Bach JF; Bougnères PF
    J Autoimmun; 1996 Dec; 9(6):739-45. PubMed ID: 9115576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics.
    Olmos PR; Hodgson MI; Maiz A; Manrique M; De Valdés MD; Foncea R; Acosta AM; Emmerich MV; Velasco S; Muñiz OP; Oyarzún CA; Claro JC; Bastías MJ; Toro LA
    Diabetes Res Clin Pract; 2006 Mar; 71(3):320-33. PubMed ID: 16233932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children at high risk of diabetes mellitus: New York studies of families with diabetes and of children with congenital rubella syndrome.
    McEvoy RC; Fedun B; Cooper LZ; Thomas NM; Rodriguez de Cordoba S; Rubinstein P; Ginsberg-Fellner F
    Adv Exp Med Biol; 1988; 246():221-7. PubMed ID: 3074654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.